THERAPEUTIC ADVANTAGES OF MONITORING PLASMA-CONCENTRATIONS OF PERPHENAZINE IN CLINICAL-PRACTICE

被引：18

作者：

HANSEN, LB

LARSEN, NE

机构：

[1] GLOSTRUP HOSP,DEPT CLIN CHEM,CLIN PHARMACOL LAB,DK-2600 GLOSTRUP,DENMARK

[2] NORDVANG MENTAL HOSP,DEPT P,DK-2600 GLOSTRUP,DENMARK

来源：

PSYCHOPHARMACOLOGY | 1985年 / 87卷 / 01期

关键词：

D O I：

10.1007/BF00431770

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：16 / 19

页数：4

相关论文

共 14 条

[1] PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS
COOPER, TB
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (01) : 14 - 38
[2] ERICKSEN S E, 1978, Psychopharmacology Bulletin, V14, P15
[3] EXTEIN I, 1982, Psychopharmacology Bulletin, V18, P156
[4] FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396
[5] HANSEN CE, 1976, BRIT J CLIN PHARMACO, V3, P915
[6] DOSE-RESPONSE RELATIONSHIPS OF PERPHENAZINE IN THE TREATMENT OF ACUTE PSYCHOSES
HANSEN, LB
LARSEN, NE
GULMANN, N
[J]. PSYCHOPHARMACOLOGY, 1982, 78 (02) : 112 - 115
[7] PLASMA CONCENTRATIONS OF PERPHENAZINE AND ITS SULFOXIDE METABOLITE DURING CONTINUOUS ORAL TREATMENT
HANSEN, LB
LARSEN, NE
[J]. PSYCHOPHARMACOLOGY, 1977, 53 (02) : 127 - 130
[8] PLASMA-LEVELS OF PERPHENAZINE (TRILAFON) RELATED TO DEVELOPMENT OF EXTRAPYRAMIDAL SIDE-EFFECTS
HANSEN, LB
LARSEN, NE
VESTERGARD, P
[J]. PSYCHOPHARMACOLOGY, 1981, 74 (04) : 306 - 309
[9] PLASMA-LEVELS OF PERPHENAZINE AND ITS MAJOR METABOLITES DURING SIMULTANEOUS TREATMENT WITH ANTICHOLINERGIC DRUGS
HANSEN, LB
ELLEY, J
CHRISTENSEN, TR
LARSEN, NE
NAESTOFT, J
HVIDBERG, EF
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (01) : 75 - 80
[10] FACTORS INFLUENCING NORTRIPTYLINE STEADY-STATE KINETICS - PLASMA AND SALIVA LEVELS
KRAGHSORENSEN, P
LARSEN, NE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) : 796 - 803